Literature DB >> 28717899

The Effects of Public Disclosure of Industry Payments to Physicians on Patient Trust: A Randomized Experiment.

Alison R Hwong1,2, Sunita Sah3, Lisa Soleymani Lehmann4,5,6.   

Abstract

BACKGROUND: Financial ties between physicians and the pharmaceutical and medical device industry are common, but little is known about how patient trust is affected by these ties.
OBJECTIVE: The purpose of this study was to evaluate how viewing online public disclosure of industry payments affects patients' trust ratings for physicians, the medical profession, and the pharmaceutical and medical device industry.
DESIGN: This was a randomized experimental evaluation. PARTICIPANTS: There were 278 English-speaking participants over age 18 who had seen a healthcare provider in the previous 12 months who took part in the study.
INTERVENTIONS: Participants searched for physicians on an online disclosure database, viewed payments from industry to the physicians, and assigned trust ratings. Participants were randomized to view physicians who received no payment ($0), low payment ($250-300), or high payment (>$13,000) from industry, or to a control arm in which they did not view the disclosure website. They also were asked to search for and then rate trust in their own physician. MAIN MEASURES: Primary outcomes were trust in individual physician, medical profession, and industry. These scales measure trust as a composite of honesty, fidelity, competence, and global trust. KEY
RESULTS: Compared to physicians who received no payments, physicians who received payments over $13,000 received lower ratings for honesty [mean (SD): 3.36 (0.86) vs. 2.75 (0.95), p < 0.001] and fidelity [3.19 (0.65) vs. 2.89 (0.68), p = 0.01]. Among the 7.9% of participants who found their own physician on the website, ratings for honesty and fidelity decreased as the industry payment to the physician increased (honesty: Spearman's ρ = -0.52, p = 0.02; fidelity: Spearman's ρ = -0.55, p = 0.01). Viewing the disclosure website did not affect trust ratings for the medical profession or industry.
CONCLUSIONS: Disclosure of industry payments to physicians affected perceptions of individual physician honesty and fidelity, but not perceptions of competence. Disclosure did not affect trust ratings for the medical profession or the pharmaceutical and medical device industry. ClinicalTrials.gov identifier: NCT02179632 ( https://clinicaltrials.gov/ct2/show/NCT02179632 ).

Entities:  

Mesh:

Year:  2017        PMID: 28717899      PMCID: PMC5653550          DOI: 10.1007/s11606-017-4122-y

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  35 in total

Review 1.  Trust in physicians and medical institutions: what is it, can it be measured, and does it matter?

Authors:  M A Hall; E Dugan; B Zheng; A K Mishra
Journal:  Milbank Q       Date:  2001       Impact factor: 4.911

2.  Trust in the medical profession: conceptual and measurement issues.

Authors:  Mark A Hall; Fabian Camacho; Elizabeth Dugan; Rajesh Balkrishnan
Journal:  Health Serv Res       Date:  2002-10       Impact factor: 3.402

3.  Measuring patients' trust in their primary care providers.

Authors:  Mark A Hall; Beiyao Zheng; Elizabeth Dugan; Fabian Camacho; Kristin E Kidd; Aneil Mishra; Rajesh Balkrishnan
Journal:  Med Care Res Rev       Date:  2002-09       Impact factor: 3.929

4.  Trust in the health care system and the use of preventive health services by older black and white adults.

Authors:  Donald Musa; Richard Schulz; Roderick Harris; Myrna Silverman; Stephen B Thomas
Journal:  Am J Public Health       Date:  2008-10-15       Impact factor: 9.308

5.  Sunlight as disinfectant--new rules on disclosure of industry payments to physicians.

Authors:  Meredith B Rosenthal; Michelle M Mello
Journal:  N Engl J Med       Date:  2013-05-30       Impact factor: 91.245

6.  Physicians' behavior and their interactions with drug companies. A controlled study of physicians who requested additions to a hospital drug formulary.

Authors:  M M Chren; C S Landefeld
Journal:  JAMA       Date:  1994-03-02       Impact factor: 56.272

7.  Medicare, Medicaid, Children's Health Insurance Programs; transparency reports and reporting of physician ownership or investment interests. Final rule.

Authors: 
Journal:  Fed Regist       Date:  2013-02-08

Review 8.  The impact of disclosing financial ties in research and clinical care: a systematic review.

Authors:  Adam Licurse; Emma Barber; Steve Joffe; Cary Gross
Journal:  Arch Intern Med       Date:  2010-04-26

9.  Effects of disclosing financial interests on attitudes toward clinical research.

Authors:  Kevin P Weinfurt; Mark A Hall; Michaela A Dinan; Venita DePuy; Joëlle Y Friedman; Jennifer S Allsbrook; Jeremy Sugarman
Journal:  J Gen Intern Med       Date:  2008-04-02       Impact factor: 5.128

10.  The association of patient trust and self-care among patients with diabetes mellitus.

Authors:  Denise E Bonds; Fabian Camacho; Ronny A Bell; Vanessa T Duren-Winfield; Roger T Anderson; David C Goff
Journal:  BMC Fam Pract       Date:  2004-11-16       Impact factor: 2.497

View more
  8 in total

1.  Capsule Commentary on Hwong et al., The Effects of Public Disclosure of Industry Payments to Physicians on Patient Trust: A Randomized Experiment.

Authors:  Amir Mohammad
Journal:  J Gen Intern Med       Date:  2017-11       Impact factor: 5.128

2.  Review of Industry Payments to General Orthopaedic Surgeons Reported by the Open Payments Database: 2014 to 2019.

Authors:  Johann Braithwaite; Nicholas Frane; Matthew J Partan; Peter B White; Cesar Iturriaga; Joshua Gruber; Adam Bitterman
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2021-05-07

3.  A Ray of Sunshine: Transparency in Physician-Industry Relationships Is Not Enough.

Authors:  Joel Lexchin; Adriane Fugh-Berman
Journal:  J Gen Intern Med       Date:  2021-03-10       Impact factor: 6.473

4.  Towards Patient-Centered Conflicts of Interest Policy.

Authors:  Peter D Young; Dawei Xie; Harald Schmidt
Journal:  Int J Health Policy Manag       Date:  2018-02-01

5.  Financial conflicts of interest of clinicians making submissions to the pan-Canadian Oncology Drug Review: a descriptive study.

Authors:  Joel Lexchin
Journal:  BMJ Open       Date:  2019-07-26       Impact factor: 2.692

6.  Pharmaceutical Sales Representatives in the United States and China: The Need for Professional Public Space.

Authors:  Xiaoying Chen
Journal:  Health Care Anal       Date:  2021-11-11

Review 7.  Assessment of Pharmaceutical Company and Device Manufacturer Payments to Gastroenterologists and Their Participation in Clinical Practice Guideline Panels.

Authors:  Salman Nusrat; Taseen Syed; Sanober Nusrat; Sixia Chen; Wei-Jen Chen; Klaus Bielefeldt
Journal:  JAMA Netw Open       Date:  2018-12-07

8.  French Public Familiarity and Attitudes toward Clinical Research during the COVID-19 Pandemic.

Authors:  Émilien Schultz; Jeremy K Ward; Laëtitia Atlani-Duault; Seth M Holmes; Julien Mancini
Journal:  Int J Environ Res Public Health       Date:  2021-03-05       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.